M Krámer

1.8k total citations
28 papers, 1.3k citations indexed

About

M Krámer is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, M Krámer has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 6 papers in Hematology. Recurrent topics in M Krámer's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (3 papers). M Krámer is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (3 papers). M Krámer collaborates with scholars based in Netherlands, United States and Germany. M Krámer's co-authors include J. Han van Krieken, Daphne de Jong, Jos Hermans, Hanneke C. Kluin‐Nelemans, P.M. Kluin, Katja Philippo, Ed Schuuring, Eric Geelen, E. Maartense and P. M. Kluin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

M Krámer

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Krámer Netherlands 12 815 584 378 189 161 28 1.3k
Răzvan Popescu Switzerland 17 510 0.6× 927 1.6× 273 0.7× 141 0.7× 35 0.2× 63 1.7k
Robert W. Chen United States 16 521 0.6× 497 0.9× 188 0.5× 218 1.2× 110 0.7× 76 1.0k
Teresa Salvadó-Usach Spain 14 492 0.6× 524 0.9× 111 0.3× 126 0.7× 51 0.3× 37 1.1k
Aliyah R. Sohani United States 27 1.7k 2.1× 1.1k 1.9× 1.1k 3.0× 568 3.0× 370 2.3× 106 3.1k
Raymond E. Lenhard United States 17 349 0.4× 394 0.7× 173 0.5× 155 0.8× 131 0.8× 49 998
Albert Assad United States 13 216 0.3× 250 0.4× 191 0.5× 152 0.8× 30 0.2× 43 826
Manuel M. Morente Spain 25 515 0.6× 506 0.9× 121 0.3× 622 3.3× 74 0.5× 53 1.6k
Kim Linton United Kingdom 24 1.2k 1.4× 1.1k 1.8× 542 1.4× 421 2.2× 408 2.5× 122 2.2k
Arianna Simonetti Italy 9 361 0.4× 342 0.6× 299 0.8× 165 0.9× 58 0.4× 16 1.1k
Elena Guerini‐Rocco Italy 27 449 0.6× 1.2k 2.0× 55 0.1× 613 3.2× 102 0.6× 130 2.3k

Countries citing papers authored by M Krámer

Since Specialization
Citations

This map shows the geographic impact of M Krámer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Krámer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Krámer more than expected).

Fields of papers citing papers by M Krámer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Krámer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Krámer. The network helps show where M Krámer may publish in the future.

Co-authorship network of co-authors of M Krámer

This figure shows the co-authorship network connecting the top 25 collaborators of M Krámer. A scholar is included among the top collaborators of M Krámer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Krámer. M Krámer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walonoski, Jason, M Krámer, Joseph C. Nichols, et al.. (2017). Synthea: An approach, method, and software mechanism for generating synthetic patients and the synthetic electronic health care record. Journal of the American Medical Informatics Association. 25(3). 230–238. 213 indexed citations
2.
Krámer, M, et al.. (2016). Ganciclovir-induced ataxia and encephalopathy.. PubMed. 74(10). 449–450. 1 indexed citations
3.
Moritz, Andreas, et al.. (2015). Hemostatic variables, plasma lactate concentration, and inflammatory biomarkers in dogs with gastric dilatation-volvulus. Tierärztliche Praxis Ausgabe K Kleintiere / Heimtiere. 43(6). 389–398. 6 indexed citations
4.
Klumpp, S., et al.. (2013). Die computertomographische Morphologie und Anatomie des Ellbogengelenkes mit Schwerpunkt des Processus coronoideus medialis ulnae bei mit ED 0 beurteilten Hunden spezieller Rassen. Kleintierpraxis. 58. 2 indexed citations
5.
Nanayakkara, Prabath W.B., et al.. (2010). What have we here? A man or a fish?. The Lancet. 376(9753). 1710–1710. 2 indexed citations
6.
Krámer, M, Michael Schenk, J. Lange, et al.. (2010). Aus dem Labor in die Klinik: Die erste transgastrisch-flexible NOTES-Laparoskopie in Deutschland. Zeitschrift für Gastroenterologie. 48(8). 1 indexed citations
7.
Mik, L. Timmer‐de, Sylvia H. Kardaun, M Krámer, Donal P. Hayes, & M.T. Bousema. (2008). Imatinib-induced pseudoporphyria. Clinical and Experimental Dermatology. 34(6). 705–707. 11 indexed citations
8.
Krámer, M, et al.. (2008). Wiki trust metrics based on phrasal analysis. 1–10. 16 indexed citations
9.
Oosterheert, Jan Jelrik, M.T. Bousema, Jaap H. Lagendijk, & M Krámer. (2006). Blue rubber bleb nevus syndrome co-existing with celiac disease.. PubMed. 64(11). 431–4. 1 indexed citations
10.
Daenen, Simon, Bronno van der Holt, Gregor Verhoef, et al.. (2004). Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:. Leukemia Research. 28(10). 1057–1067. 30 indexed citations
11.
Krámer, M, Jos Hermans, Katja Philippo, et al.. (1998). Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma. Blood. 92(9). 3152–3162. 43 indexed citations
12.
Krol, Augustinus D. G., J. Hermans, M Krámer, et al.. (1997). Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival. Cancer. 79(2). 390–397. 22 indexed citations
13.
Krámer, M, Jos Hermans, Jefferson Parker, et al.. (1996). Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 14(7). 1 indexed citations
14.
Velders, Gerjo A., Hanneke C. Kluin‐Nelemans, Carla J. de Boer, et al.. (1996). Mantle-cell lymphoma. Journal of Clinical Oncology. 14(4). 3 indexed citations
15.
Velders, Gerjo A., Hanneke C. Kluin‐Nelemans, Carla J. de Boer, et al.. (1996). Mantle-cell lymphoma: a population-based clinical study.. Journal of Clinical Oncology. 14(4). 1269–1274. 143 indexed citations
16.
Krámer, M, J. Hermans, Jefferson Parker, et al.. (1996). Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.. Journal of Clinical Oncology. 14(7). 2131–2138. 175 indexed citations
17.
Krámer, M, et al.. (1996). [Ultrasonic studies in reptiles].. PubMed. 109(4). 136–41. 4 indexed citations
18.
19.
Krámer, M, et al.. (1995). Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes.. PubMed. 9(10). 1748–55. 16 indexed citations
20.
Krámer, M. (1982). Excessive cerumen production due to the aromatic retinoid Tigason in a patient with Darier´s disease. Acta Dermato Venereologica. 62(3). 267–268. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026